Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sunesis begins phase I trial of MLN-2480

Sep. 29, 2011

Riemser Arzneimittel receives German license for CINV combination therapy

Sep. 29, 2011

CytRx to increase enrollment in INNO-206 clinical trial

Sep. 28, 2011

Photocure and Ipsen to commercialize Hexvix

Sep. 28, 2011

CHMP issues opinion on new indication for Avastin

Sep. 28, 2011

CHMP recommends approval of Alimta for new indication

Sep. 27, 2011

Ono Pharmaceutical obtains approval in Japan for intravenous Proemend

Sep. 27, 2011

Piramal Life Sciences patents novel TGF-beta inhibitors for cancer

Sep. 27, 2011

Additional FDA orphan drug designation for resminostat

Sep. 27, 2011

Novel compositions for regulating HER4 reported

Sep. 27, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...